Don't miss

Replay


LATEST SHOWS

THE DEBATE

Next stop, Westminster: Supreme Court orders Brexit parliament vote (part 1)

Read more

THE DEBATE

Next stop, Westminster: Supreme Court orders Brexit parliament vote (part 2)

Read more

FOCUS

Iranian women push boundaries through sport

Read more

MEDIAWATCH

Crowds, Lies & Alternative Facts

Read more

ENCORE!

Backstage at the Haute Couture show of designer Julien Fournié

Read more

BUSINESS DAILY

President Trump pulls US out of TPP trade deal

Read more

IN THE PAPERS

'Donald Trump is rolling back the clock on diversity in the cabinet'

Read more

IN THE PAPERS

Did France's left inflate turnout figures in round one of the primary?

Read more

ACROSS AFRICA

Dozens killed in attack on military camp in Mali

Read more

Americas

Obama earmarks $1.8 billion for fight against pandemic

Text by NEWS WIRES

Latest update : 2009-07-16

US President Barack Obama has designated more than $1.8 billion in emergency funds to fight a pandemic of influenza A(H1N1), or swine flu. The money will mainly go toward producing vaccines and helping plan immunisation campaigns.

REUTERS - President Barack Obama designated $1.825 billion on Thursday for emergency use to fight the new pandemic of H1N1 swine flu.

 

The money will go to buy vaccine ingredients, to help health officials plan immunization campaigns and to help get the vaccines approved at the U.S. Food and Drug Administration, Obama said in a letter to House of Representatives Speaker Nancy Pelosi.

 

"To enhance our nation's capability to respond to the potential spread of this outbreak, and in accordance with the appropriation, I hereby designate $1.825 billion of the contingent appropriation as emergency funds required to address critical needs related to emerging influenza viruses (specifically, the virus known as 2009-H1N1)," Obama wrote.

 

The money comes from $7.65 billion Congress already appropriated to the Department of Health and Human Services for the swine flu pandemic.

 

The World Health Organization said earlier on Thursday that the H1N1 flu pandemic was the fastest-moving ever and that it was now pointless to count every case.

 

WHO said at least 50 governments have placed orders for vaccines and WHO vaccine chief Marie-Paule Kieny told Reuters the potential global value of the market was estimated at between $10 billion and $20 billion.

 

 Sanofi-Aventis, Novartis, Baxter, GlaxoSmithKline, and AstraZeneca's MedImmune unit all have H1N1 vaccines for the U.S. market.

 

Date created : 2009-07-16

COMMENT(S)